| Document |
Document Title |
|
WO/2021/149051A1 |
The present invention provides compounds and herbicidal compositions comprising thereof. Further, use of herbicidal compositions or kit for controlling plant growth is also provided.
|
|
WO/2021/146386A1 |
The present disclosure provides, inter alia, bivalent small molecules and methods for treating or ameliorating the effects of a disease, such as long QT syndrome, or cystic fibrosis, in a subject, using the bivalent small molecules discl...
|
|
WO/2021/142186A1 |
Discloased is a pharmaceutical composition comprising: an active ingredient of the following formula (I) or a pharmaceutically acceptable salt or solvate thereof: (I); and one or more excipient selected from the group consisting of a bin...
|
|
WO/2021/136808A1 |
The present invention relates to conjugates and pharmaceutically acceptable salts thereof, reagents, intermediates, methods for the synthesis of said conjugates, pharmaceutical compositions comprising said conjugates and the use of said ...
|
|
WO/2021/128648A1 |
The present invention relates to a method for preparing oxamide from dimethyl oxalate, comprising: 1) mixing a dimethyl oxalate stream, a methanol raw material stream and a liquid ammonia stream to perform an ammonolysis reaction to prov...
|
|
WO/2021/132365A1 |
Provided is a method for producing a highly polymerizable N-vinyl carboxylic acid amide monomer by efficiently purifying N-vinyl carboxylic acid amide. The method for producing a highly polymerizable N-vinyl carboxylic acid amide monom...
|
|
WO/2021/132364A1 |
Provided is a method with which it is possible to purify N-vinylcarboxamide efficiently and produce a highly polymerizable N-vinylcarboxamide monomer. This method for producing a highly polymerizable N-vinylcarboxamide monomer is chara...
|
|
WO/2021/132363A1 |
Provided is a method whereby an N-vinyl carboxylic acid amide can be efficiently refined to manufacture a highly polymerizable N-vinyl carboxylic acid amide monomer. This method for manufacturing a highly polymerizable N-vinyl carboxyl...
|
|
WO/2021/132367A1 |
Provided is a method with which it is possible to purify N-vinylcarboxamide efficiently and produce a highly polymerizable N-vinylcarboxamide monomer. This method for producing a highly polymerizable N-vinylcarboxamide monomer is chara...
|
|
WO/2021/132366A1 |
Provided is a method by which an N-vinylcarboxylic acid amide can be efficiently purified to produce a highly polymerizable N-vinylcarboxylic acid amide monomer. This method for producing a highly polymerizable N-vinylcarboxylic acid a...
|
|
WO/2021/127743A1 |
The present disclosure relates to substituted hydroxystilbene compounds and derivatives, specifically 2-substituted hydroxystilbene compounds and derivatives, the synthesis of such compounds and their use in therapy.
|
|
WO/2021/130451A1 |
The invention relates to chemical compounds C that are derivatives of norbixine and have tropism for the eye, and are intended to be used in the treatment of eye diseases in mammals, in particular in the context of altering the retinal p...
|
|
WO/2021/120982A1 |
The present invention relates to a method for preparing m-phenylenediamine, comprising the following steps: (1) using meta-xylene as a starting material, preparing isophthalamide; (2) reacting the isophthalamide with hypohalite or haloge...
|
|
WO/2021/120896A1 |
Provided is a preparation method for norbornane dimethylamine, comprising the following steps: a) mixing a compound having a structure shown in a formula (I) with urotropin, an acid and a first solvent, and carrying out a first reaction ...
|
|
WO/2021/119632A1 |
A trisamide compound has the structure of Formula (I) in which R1, R2, and R3 are independently selected from the group consisting of alkyl groups. A polymer composition comprises a trisamide compound of Formula (I) and a polyolefin poly...
|
|
WO/2021/119633A1 |
A trisamide compound has the structure of Formula (I) in which R1, R2, and R3 are independently selected from the group consisting of alkyl groups. A polymer composition comprises a trisamide compound of Formula (I) and a polyolefin poly...
|
|
WO/2021/117609A1 |
The present invention addresses the problem of providing a composition which stably has high polymerizability, and from which an N-vinyl acetamide polymer is produced. An N-vinyl acetamide-containing composition which is characterized ...
|
|
WO/2021/117658A1 |
Provided is a method for producing an N-vinylacetamide which can prevent raw material gas (vaporized raw material) from being liquefied by re-condensation, suppress the problem of pyrolysis reactor blockage by resin, and enable stable an...
|
|
WO/2021/110991A1 |
The present invention relates to a contrast agent suitable for ex vivo imaging, particularly of vascular structures and renal tubular structures, and a method for ex vivo imaging. The contrast agent is a polymer comprising monomers M. Th...
|
|
WO/2021/110076A1 |
The present invention belongs to the field of medicinal chemistry and relates to oxamide derivatives, a preparation method therefor and the use thereof in medicine. In particular, provided is a compound of formula (I) or a stereoisomer, ...
|
|
WO/2021/103455A1 |
Provided are a synthesis system and method for preparing adiponitrile by means of the amination of adipic acid. The synthesis system comprises an amination reactor and a reaction rectifying column that are connected in sequence; the reac...
|
|
WO/2021/105906A1 |
The application is directed to compounds of formulae (IA) and (IB): (IA) and (IB), and their salts and solvates, wherein R1a, R2a, A1, A2, A3, A4, R1b, R2b, B1, B2, B3, and G are as set forth in the specification, as well as to methods f...
|
|
WO/2021/106947A1 |
Provided are a compound represented by formula (1) or a pharmacologically acceptable salt thereof, and an antitrypanosomal drug containing the same as an active ingredient. In formula (1), X is NH or CH2, R1 is a hydrogen atom, an alkoxy...
|
|
WO/2021/103457A1 |
The present invention provides a synthetic system and method for preparing hexamethylenediamine by adiponitrile hydrogenation. The synthetic system comprises an adiponitrile preparation device, a microinterface intensifier, a hydrogenati...
|
|
WO/2021/101903A1 |
The present invention provides benzamide compounds, compositions containing the benzamides, and use of the benzamides for inhibiting androgen receptor (AR) and/or aldo-keto reductase family 1 member C3 (AKR1C3). Also described herein met...
|
|
WO/2021/099134A1 |
The present invention relates to a process for the preparation of a procatalyst suitable for preparing a catalyst composition for olefin polymerization, said process comprising the steps of: Step A) providing or preparing a Grignard comp...
|
|
WO/2021/097110A1 |
The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.
|
|
WO/2021/093697A1 |
Provided is a series of supramolecular complexes (composites) having a dual function. The supramolecular complexes (composites) comprise a compound having an angiotensin II receptor (AT1) blocking function, a neprilysin inhibitor (NEPi) ...
|
|
WO/2021/096811A1 |
Disclosed herein are tucaresol derivative compound and composition containing the same. Also disclosed herein are methods of enhancing immune response in a subject by administering the tucaresol derivative compound or by co-administering...
|
|
WO/2021/092703A1 |
The invention features methods of treating a patient after having a myocardial infarction including administering colchicine to a patient determined to have a genetic variant in the genome that is indicative of the patient benefiting fro...
|
|
WO/2021/088209A1 |
The present invention relates to a capsaicin hapten and artificial antigen for detecting illegal cooking oil, a preparation method therefor and an application thereof. The structure of the capsaicin hapten is shown as formula I or formul...
|
|
WO/2021/089030A1 |
Disclosed are the use of one or more lipid compounds in the delivery of nucleic acids, and a lipid-nucleic acid mixture, a pharmaceutical composition or a kit comprising the lipid compound and nucleic acids. The lipid compounds provided ...
|
|
WO/2021/085636A1 |
[Problem] To provide a novel means capable of generating highly stereoselective and/or highly efficient amidation reactions in a variety of substrates having a carboxyl group and an amino group, and capable of producing amide compounds. ...
|
|
WO/2021/083459A1 |
The invention relates to a process for the synthesis of DOPA comprising a photolabile protective group and to intermediates for preparing same (I), R being selected from the group that consists of 2-nitrobenzyl,1-(2-nitrophenyl)ethyl, 7-...
|
|
WO/2021/086754A1 |
Aspects of the disclosure include crystalline solids of 3-palmitoyl-amido-1,2- propanediol and 3-palmitoyl-amido-2-hydroxy-1-dimethoxytriphenylmethylether-
propane. Methods for preparing the crystalline solids of 3-palmitoyl-amido-1,2- p...
|
|
WO/2021/085635A1 |
The present invention provides a novel means capable of producing an amide compound by highly stereoselectively and/or highly efficiently causing an amide reaction in various substrates having a carboxyl group and an amino group. This ...
|
|
WO/2021/074842A1 |
Aspects of the present application relate to crystalline and amorphous solid forms of Diroximel fumarate, pharmaceutical compositions and processes thereof. Further, aspects relate to improved processes for the preparation of Diroximel f...
|
|
WO/2021/074808A1 |
The present invention relates to a pharmaceutical composition comprising amorphous sacubitril valsartan trisodium complex with copovidone and poloxamer and a process for preparing the composition thereof. The present invention also relat...
|
|
WO/2021/070941A1 |
The present invention provides a surfactant which has good lathering properties, good lather quality and solubility even in a weak acidic range where the pH is equivalent to that of the skin, while having a low viscosity that leads to hi...
|
|
WO/2021/065893A1 |
The purpose of the present invention is to provide a novel low-molecular-weight compound that exhibits agonistic activity on an orexin receptor and is expected to be useful as a prophylactic or therapeutic agent for narcolepsy and the li...
|
|
WO/2021/063373A1 |
The present invention relates to a compound represented by formula I and a stereoisomer, tautomer, solvate, polymorph thereof or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing same, a preparation meth...
|
|
WO/2021/059146A1 |
The present invention relates to a process for preparing 1,1,3 -trimethylindan-4-amine of formula (I), or a salt thereof, enriched in one of its two enantiomers, in particular the enantiomer (R), (I) which comprises the chiral separation...
|
|
WO/2021/062348A1 |
The present invention provides methods of reducing injury to rice and achieving weed control by treating the rice with both a safener and a microencapsulated Group 15 herbicide. Herein, the inventors demonstrate that the tolerance of fen...
|
|
WO/2021/059287A1 |
A method of oxygenating a benzylic C-H bond is provided. The method comprises light induced activation of an initiator and subsequent reaction with oxygen, resulting in the formation of free radicals. Subsequently, free radicals catalyze...
|
|
WO/2021/046651A1 |
Provided herein are compounds of Formula A, methods for the preparation thereof, and uses thereof for treating or preventing bacterial infections.
|
|
WO/2021/050992A1 |
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of USP30, and the treatment of USP30-mediated disorders.
|
|
WO/2021/036256A1 |
The present application is suitable for use in the technical field of drug synthesis, and provides a method for synthesizing an HIV protease inhibitor intermediate compounds. The method comprises subjecting compound 1a to an asymmetric t...
|
|
WO/2021/033504A1 |
A method for producing a carbonyl compound by means of a flow reaction, wherein: a triphosgene solution is introduced into a flow path (I); the triphosgene solution comes into contact with a solid catalyst, which is affixed to at least a...
|
|
WO/2021/033505A1 |
A method for producing a carbonyl compound by means of a flow reaction, wherein: a triphosgene solution, a tertiary amine solution and an active hydrogen-containing compound solution are introduced into different flow paths and are cause...
|
|
WO/2021/034863A1 |
Capsaicin compositions and methods for enhancing hydrophobicity of a molecule useful for pharmaceutical applications, including: (1) a prodrug using a linker such as a carbamate between capsaicin with other structures in order to optimiz...
|
